Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: The impact of the infection type and the presence of vegetation on survival

Europace

Volumn 16, Issue 10, 2014, Pages 1490-1495

  Tarakji, Khaldoun G ^a   Wazni, Oussama M ^a   Harb, Serge ^a   Hsu, Amy ^a   Saliba, Walid ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac implantable electronic device; CIED; Complication; Defibrillator; Extraction; Infection; Mortality; Pacemaker

Indexed keywords

AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIAC IMPLANT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; DEVICE INFECTION; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ARTIFICIAL HEART PACEMAKER; DEVICE REMOVAL; ECHOGRAPHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFECTION; MEDICAL DEVICE CONTAMINATION; SURVIVAL RATE;

AGED; DEFIBRILLATORS, IMPLANTABLE; DEVICE REMOVAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; SURVIVAL RATE;

EID: 84933053363     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu147     Document Type: Article

References (18)

1. Hayes DL, Furman S. Cardiac pacing: how it started, where we are, where we are going. Pacing Clin Electrophysiol 2004;27:693-704.
2. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM et al. HRS/ EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008;5:907-25.
3. Tarakji KG, Wilkoff BL. Management of cardiac implantable electronic device infections: the challenges of understanding the scope of the problem and its associated mortality. Expert Rev Cardiovasc Ther 2013;11:607-16.
4. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-18.
5. Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin Electrophysiol 2004;27: 955-64.
6. Uslan DZ, Tleyjeh IM, Baddour LM, Friedman PA, Jenkins SM, St Sauver JL et al. Temporal trends in permanent pacemaker implantation: a population-based study. Am Heart J 2008;155:896-903.
7. Golzio PG, Fanelli AL, Vinci M, Pelissero E, Morello M, Grosso MarraWet al. Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects. Europace 2013;15:89-100.
8. Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S et al. Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm 2010;7:1043-7.
9. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol 2006;48:590-1.
10. Sohail MR, Uslan DZ, Khan AH, Friedman PA, Hayes DL, WilsonWRet al. Management and outcome of permanent pacemaker and implantable cardioverterdefibrillator infections. J Am Coll Cardiol 2007;49:1851-9.
11. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol 2009;2:129-34.
12. Le KY, SohailMR, Friedman PA, Uslan DZ, Cha SS, HayesDL et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm 2011;8:1678-85.
13. Deharo JC, Quatre A, Mancini J, Khairy P, Le DolleyY, Casalta JP et al. Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study. Heart 2012;98:724-31.
14. Athan E,Chu VH, Tattevin P, Selton-Suty C, Jones P, NaberCet al. Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 2012;307:1727-35.
15. Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med 2011;171:1821-8.
16. Deckx S, Marynissen T, Rega F, Ector J, Nuyens D, Heidbuchel H et al. Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience. Europace 2014;16:1218-25.
17. de Bie MK, van Rees JB, Thijssen J, Borleffs CJ, Trines SA, Cannegieter SC et al. Cardiac device infections are associated with a significant mortality risk. Heart Rhythm 2012;9:494-8.
18. Habib A, Le KY, Baddour LM, Friedman PA, Hayes DL, Lohse CMet al. Predictors of mortality in patients with cardiovascular implantable electronic device infections. Am J Cardiol 2013;111:874-9.